These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20308723)

  • 1. High ghrelin and obestatin levels and low risk of developing fatty liver.
    Gutierrez-Grobe Y; Villalobos-Blasquez I; Sánchez-Lara K; Villa AR; Ponciano-Rodríguez G; Ramos MH; Chavez-Tapia NC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2010; 9(1):52-7. PubMed ID: 20308723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women.
    Vicennati V; Genghini S; De Iasio R; Pasqui F; Pagotto U; Pasquali R
    Eur J Endocrinol; 2007 Sep; 157(3):295-301. PubMed ID: 17766711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin and obestatin levels in hypertensive obese patients.
    Wang WM; Li SM; Du FM; Zhu ZC; Zhang JC; Li YX
    J Int Med Res; 2014 Dec; 42(6):1202-8. PubMed ID: 25186095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ghrelin and obestatin levels and ghrelin/obestatin ratio in patients with asthma.
    Kızılırmak D; Bozkurt B; Karamanlı H
    Tuberk Toraks; 2020 Mar; 68(1):9-16. PubMed ID: 32718135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible association of ghrelin/obestatin balance with cardiometabolic risk in obese subjects with Helicobacter pylori.
    Ibrahim AS; Eldeeb MM; Salama OA; Rashad MM; Okasha KM
    Endocr Regul; 2018 Apr; 52(2):101-109. PubMed ID: 29715187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa.
    Nakahara T; Harada T; Yasuhara D; Shimada N; Amitani H; Sakoguchi T; Kamiji MM; Asakawa A; Inui A
    Biol Psychiatry; 2008 Aug; 64(3):252-5. PubMed ID: 17919459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
    Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
    Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation.
    Khaleel EF; Abdel-Aleem GA
    Arch Physiol Biochem; 2019 Feb; 125(1):64-78. PubMed ID: 29429367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
    Park SH; Kim BI; Kim SH; Kim HJ; Park DI; Cho YK; Sung IK; Sohn CI; Kim H; Keum DK; Kim HD; Park JH; Kang JH; Jeon WK
    J Am Coll Nutr; 2007 Aug; 26(4):321-6. PubMed ID: 17906183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of serum obestatin expression with insulin resistance in childhood obesity.
    Zhang MY; Li F; Wang JP
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28453173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.
    Marchesini G; Pagotto U; Bugianesi E; De Iasio R; Manini R; Vanni E; Pasquali R; Melchionda N; Rizzetto M
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5674-9. PubMed ID: 14671152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating obestatin levels correlate with fasting insulin and HOMA-IR but not with hypertension in elderly men.
    Shao L; Zhao YT; Teng LL; Li MZ; Jiang H
    Cell Biochem Biophys; 2014 May; 69(1):89-92. PubMed ID: 24197679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?].
    Graffigna MN; Belli SH; de Larrañaga G; Fainboim H; Estepo C; Peres S; García N; Levalle O
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):30-7. PubMed ID: 19408737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease.
    Estep M; Abawi M; Jarrar M; Wang L; Stepanova M; Elariny H; Moazez A; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    Obes Surg; 2011 Nov; 21(11):1750-7. PubMed ID: 21744131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The change in ghrelin and obestatin levels in obese children after weight reduction.
    Zou CC; Liang L; Wang CL; Fu JF; Zhao ZY
    Acta Paediatr; 2009 Jan; 98(1):159-65. PubMed ID: 18710433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
    Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
    Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
    Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.